Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine combined with intra-articular injection for knee osteoarthritis
NCT04117893Phase 4Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of duloxetine in osteoarthritis (OA) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Weekly mean of the 24h average pain scores at 24 weeks. Started Oct 2019; status: completed.
02
Drugs
duloxetine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04117893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04117893.